Welch Group, LLC Amgen Inc Transaction History

Welch Group, LLC

$2.29 Billion
Q3 2024

A detailed history of Welch Group, LLC transactions in Amgen Inc stock. As of the latest transaction made, Welch Group, LLC holds 852 shares of AMGN stock, worth $250,488. This represents 0.01% of its overall portfolio holdings.

Number of Shares

852

Previous 852 -0.0%

Holding current value

$250,488

Previous $266,000 3.01%

% of portfolio

0.01%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 17, 2024	BUY	$262.75 - $319.31 $262 - $319	1 Added 0.12%	852 $266,000
Q1 2024 Apr 09, 2024	BUY	$268.87 - $324.56 $228,808 - $276,200	851 New	851 $241,000
Q4 2020 Jan 25, 2021	SELL	$216.38 - $257.67 $276,533 - $329,302	-1,278 Closed	0 $0
Q3 2020 Oct 28, 2020	SELL	$234.65 - $260.95 $88,228 - $98,117	-376 Reduced 22.73%	1,278 $325,000
Q2 2020 Jul 22, 2020	SELL	$197.81 - $242.74 $1,780 - $2,184	-9 Reduced 0.54%	1,654 $390,000
Q1 2020 Apr 28, 2020	BUY	$182.24 - $241.7 $19,864 - $26,345	109 Added 7.01%	1,663 $337,000
Q4 2019 Jan 24, 2020	BUY	$189.21 - $243.2 $60,168 - $77,337	318 Added 25.73%	1,554 $375,000
Q3 2019 Nov 05, 2019	BUY	$174.11 - $208.62 $10,272 - $12,308	59 Added 5.01%	1,236 $239,000
Q2 2019 Jul 11, 2019	SELL	$166.7 - $195.41 $28,672 - $33,610	-172 Reduced 12.75%	1,177 $217,000
Q1 2019 Apr 15, 2019	BUY	$180.87 - $203.88 $31,109 - $35,067	172 Added 14.61%	1,349 $256,000
Q1 2018 Apr 23, 2018	BUY	$169.43 - $198.0 $55,064 - $64,350	325 Added 38.15%	1,177 $201,000
Q4 2017 Feb 01, 2018	BUY	$168.79 - $188.59 $143,809 - $160,678	852 New	852 $148,000
Q3 2017 Nov 07, 2017	SELL	$167.29 - $191.0 $621,147 - $709,183	-3,713 Closed	0 $0
Q2 2017 Aug 07, 2017	BUY	N/A	3,713	3,713 $639,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $157B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Welch Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Welch Group, LLC with notifications on news.

Account